These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3588607

  • 1. Adenosine receptors: development of selective agonists and antagonists.
    Daly JW, Jacobson KA, Ukena D.
    Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607
    [Abstract] [Full Text] [Related]

  • 2. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE, Hide I, Daly JW, Rothenhäusler K, Eger K.
    J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
    [Abstract] [Full Text] [Related]

  • 3. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT, Ukena D, Padgett WL, Daly JW.
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [Abstract] [Full Text] [Related]

  • 4. Xanthine functionalized congeners as potent ligands at A2-adenosine receptors.
    Jacobson KA, Ukena D, Padgett W, Daly JW, Kirk KL.
    J Med Chem; 1987 Jan; 30(1):211-4. PubMed ID: 3806597
    [Abstract] [Full Text] [Related]

  • 5. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J.
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [Abstract] [Full Text] [Related]

  • 6. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [Abstract] [Full Text] [Related]

  • 7. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
    Ukena D, Padgett WL, Hong O, Daly JW, Daly DT, Olsson RA.
    FEBS Lett; 1987 May 11; 215(2):203-8. PubMed ID: 3582647
    [Abstract] [Full Text] [Related]

  • 8. Caffeine analogs: structure-activity relationships at adenosine receptors.
    Daly JW, Hide I, Müller CE, Shamim M.
    Pharmacology; 1991 May 11; 42(6):309-21. PubMed ID: 1658821
    [Abstract] [Full Text] [Related]

  • 9. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D, Jacobson KA, Padgett WL, Ayala C, Shamim MT, Kirk KL, Olsson RO, Daly JW.
    FEBS Lett; 1986 Dec 01; 209(1):122-8. PubMed ID: 3803571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Linden J, Patel A, Earl CQ, Craig RH, Daluge SM.
    J Med Chem; 1988 Apr 01; 31(4):745-51. PubMed ID: 3351850
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA, Kusachi S, Thompson RD, Ukena D, Padgett W, Daly JW.
    J Med Chem; 1986 Sep 01; 29(9):1683-9. PubMed ID: 3018244
    [Abstract] [Full Text] [Related]

  • 14. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
    Thompson RD, Secunda S, Daly JW, Olsson RA.
    J Med Chem; 1991 Sep 01; 34(9):2877-82. PubMed ID: 1895305
    [Abstract] [Full Text] [Related]

  • 15. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
    Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK.
    J Med Chem; 1990 Aug 01; 33(8):2240-54. PubMed ID: 2374150
    [Abstract] [Full Text] [Related]

  • 16. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
    Jacobson KA, Kirk KL, Padgett WL, Daly JW.
    Mol Pharmacol; 1986 Feb 01; 29(2):126-33. PubMed ID: 3005825
    [Abstract] [Full Text] [Related]

  • 17. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U, Ukena D, Lohse MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep 01; 330(3):212-21. PubMed ID: 2997628
    [Abstract] [Full Text] [Related]

  • 18. Definition of subclasses of adenosine receptors associated with adenylate cyclase: interaction of adenosine analogs with inhibitory A1 receptors and stimulatory A2 receptors.
    Ukena D, Olsson RA, Daly JW.
    Can J Physiol Pharmacol; 1987 Mar 01; 65(3):365-76. PubMed ID: 3580959
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
    Ukena D, Shamim MT, Padgett W, Daly JW.
    Life Sci; 1986 Aug 25; 39(8):743-50. PubMed ID: 3016449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.